BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for BioLineRx Ltd. (BLRX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for BioLineRx Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2020-11-03
4:39 pm
Sale		2020-10-3013GBioLineRx Ltd.
BLRX		BIOTECHNOLOGY VALUE FUND L P148,671
1.900%		-632,391decrease
(-80.97%)		Filing
2020-06-01
5:37 pm
Sale		2020-05-2813GBioLineRx Ltd.
BLRX		BIOTECHNOLOGY VALUE FUND L P781,062
11.800%		-17,498decrease
(-2.19%)		Filing